Company Number: 12809798

Analysis Date: 2025-07-20 16:47 UTC

Financial Health Assessment for Accufix Elite Ltd as of 31 March 2024

---

1. Financial Health Score: C

Explanation:
Accufix Elite Ltd demonstrates a modest improvement in financial health compared to prior years, with positive net current assets and shareholders’ funds. However, the overall scale of operations is small with limited cash reserves and ongoing liabilities that require attention. The score reflects a company showing signs of recovery from previous distress but still maintaining a fragile liquidity position that necessitates prudent financial management.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Current Assets	11,134	Indicates short-term resources available, including cash, debtors, and stock; increased since last year.
Cash at Bank	1,170	Relatively low cash balance, signaling limited immediate liquidity “fuel” for operations.
Trade Debtors	3,141	Higher than prior year; signals sales on credit which may affect cash flow if not collected promptly.
Current Liabilities	9,897	Short-term debts increased significantly; pressure on cash flow to meet obligations.
Net Current Assets	1,237	Positive working capital indicates a healthier "pulse" but remains modest for operational demands.
Shareholders’ Funds	1,237	Positive equity after years of losses, showing recovery in retained earnings.
Stock (Inventory)	3,137	Inventory levels are moderate; watch for obsolescence or slow-moving stock.
Average Employees	3	Small workforce consistent with micro/small entity status; limits scale but controls overhead.

---

3. Diagnosis: Financial "Health" and Underlying Symptoms

• Liquidity Condition ("Cash Flow Health"):
  Cash reserves are low (£1,170), which is a symptom of tight liquidity. Despite positive net current assets, the company’s cash buffer is narrow given the current liabilities of nearly £10k. This suggests a risk of short-term cash flow stress if receivables are delayed or expenses spike.

• Working Capital ("Circulatory System"):
  Positive net current assets of £1,237 indicate the company’s short-term assets exceed short-term liabilities, a healthy sign absent in previous years (e.g. negative working capital in 2021 and 2020). This improvement suggests better management of payables and receivables.

• Profitability and Retained Earnings ("Body Mass"):
  The retained earnings have turned positive (£937) from prior negative balances, signaling profitable operations or improved financial performance. However, the scale is small and vulnerable to adverse shocks.

• Growth and Business Activity ("Metabolism"):
  The increase in trade debtors from £987 to £3,141 may indicate increased sales activity but also a potential symptom of extended credit terms or slower collections, which can strain cash flow.

• Financial Stability ("Immune System"):
  The company remains reliant on a single majority shareholder (75-100% control by Mr. Thomas Gillick), which may limit external capital but can ensure decisive governance. The departure of two directors in Feb 2024 could indicate organizational changes.

---

4. Recommendations: Prescriptions for Financial Wellness

• Enhance Cash Flow Monitoring and Management:
  Implement rigorous credit control to improve debtor collections and convert trade receivables into cash faster. Consider negotiating extended payment terms with suppliers to ease pressure on cash.

• Build Cash Reserves:
  Prioritize building a cash buffer to cover at least 3 months of current liabilities. This could be achieved by better timing of payments or seeking short-term financing facilities if necessary.

• Inventory Management:
  Review stock levels for slow-moving or obsolete items to free up working capital and avoid tying up funds unnecessarily.

• Profitability Focus:
  Continue to improve margins and reduce expenses to build retained earnings further, providing a stronger equity base and financial resilience.

• Governance and Leadership Stability:
  Address any operational impact from director resignations by ensuring clear management roles and continuity to maintain strategic focus.

• Explore Growth Opportunities Carefully:
  With modest resources, growth should be managed cautiously to avoid overextension that could exacerbate liquidity constraints.

---

Executive Summary

Accufix Elite Ltd shows signs of financial recovery with positive working capital and shareholders’ funds as of March 2024, improving from prior years of distress. However, low cash reserves and increasing current liabilities present symptoms of liquidity tension requiring active cash flow management. Focused efforts on debtor collection, cash buffer building, and operational efficiency will be critical to stabilizing and strengthening the company’s financial health going forward.